Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Work In Process (2023 - 2024)

Onconetix (ONCO) has disclosed Work In Process for 2 consecutive years, with $256148.0 as the latest value for Q1 2024.

  • On a quarterly basis, Work In Process changed N/A to $256148.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $256148.0, a N/A change, with the full-year FY2023 number at $194805.0, changed N/A from a year prior.
  • Work In Process was $256148.0 for Q1 2024 at Onconetix, up from $194805.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.1 million in Q3 2023 to a low of $194805.0 in Q4 2023.